Results 111 to 120 of about 337,494 (292)

Three Years Survival Rate of Epithelial Ovarian Cancer Patients in Dr. Kariadi Hospital, Semarang, Central Java [PDF]

open access: yes, 2016
Objectives: to determine the association between prognostic factors of ovarian cancer with a 3-years survival rate of epithelial ovarian cancer patients.Material and Method: Retrospective cohort study was conducted in 90 patients (during 2012) at Dr ...
Damayanti, I. N. (Indah)   +2 more
core  

The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit [PDF]

open access: yes, 2014
Purpose: This study aimed to establish which prognostic scoring tool provides the greatest discriminative ability when assessing critically ill cirrhotic patients in a general intensive care unit (ICU) setting.<p></p> Methods: This was a 12-
Emerson, Philip   +7 more
core   +1 more source

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells

open access: yesFrontiers in Immunology, 2017
Background Epithelial ovarian cancer (EOC) remains a highly lethal gynecological malignancy. Ascites, an accumulation of peritoneal fluid present in one-third of patients at presentation, is linked to poor prognosis.
N. Kampan   +5 more
semanticscholar   +1 more source

Chylous Ascites

open access: yesNorth American Journal of Medical Sciences, 2011
Chylous ascites is the accumulation of milky chyle in the peritoneal cavity. Chylous ascites has been reported after surgeries like abdominal aortic aneurysm repair, radical gastrectomy, duodenectomy, nephrectomy and Wilm's tumor resection. Our literature search did not reveal any reports of chylous ascites after a gastric ulcer resection.
Siva Talluri   +10 more
openaire   +2 more sources

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results

open access: yesPLoS ONE, 2017
We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed.
N. Hanafusa   +18 more
semanticscholar   +1 more source

A CASE OF CHYLIFORM ASCITES. [PDF]

open access: green, 1903
GeorgeA. Clarkson
openalex   +1 more source

Fractionation and characterization of euchromatin isolated from mouse ascites sarcoma cells [PDF]

open access: yes, 1978
Euchromatin specimen prepared by the usual method formed large clumps and had various shapes under electron microscopy. A method of separation of the euchromatin specimen into chromatin fractions having relatively homogeneous form was examined and ...
Inaba, Kozo   +2 more
core   +1 more source

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis

open access: yesAlimentary Pharmacology and Therapeutics, 2017
Refractory ascites (RA) is a frequent complication of cirrhosis, requiring large volume paracentesis or placement of a transjugular intrahepatic portosystemic shunt (TIPSS).
G. Stirnimann   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy